Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The Oncologist|April 4, 2019
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical PracticeAlessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, et al.
Blood Advances|May 5, 2026
Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE studyGiulia Gabrielli, Beatrice Casadei, Annalisa Chiappella, et al.
The Oncologist|April 21, 2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 StudyPier Luigi Zinzani, Alessandro Broccoli, Daniela Maria Gioia, et al.
Oncotarget|May 29, 2018
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphomaAlessandro Broccoli, Beatrice Casadei, Alice Morigi, et al.
The Lancet. Haematology|October 4, 2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort studyClaudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, et al.
Hematological Oncology|January 14, 2026
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient JourneyLisa Argnani, Cinzia Pellegrini, Ombretta Annibali, et al.
Blood Advances|February 23, 2022
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphomaJuan Pablo Alderuccio, Luca Arcaini, Marcus P Watkins, et al.
Haematologica|August 5, 2017
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphomaAlessandro Broccoli, Cinzia Pellegrini, Alice Di Rocco, et al.
Oncotarget|December 7, 2017
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphomaCinzia Pellegrini, Alessandro Broccoli, Alessandro Pulsoni, et al.
Pageof 10